Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Oct;53(10):4167-71.
doi: 10.1128/AAC.00874-09. Epub 2009 Aug 10.

Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis

Sang Hyoung Park  1 , Suk-Kyun Yang, Dong-Hoon Yang, Kyung Jo Kim, Soon Man Yoon, Jae Won Choe, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim
Affiliations
Randomized Controlled Trial

Prospective randomized trial of six-month versus nine-month therapy for intestinal tuberculosis

Sang Hyoung Park et al. Antimicrob Agents Chemother. 2009 Oct.

Abstract

Intestinal tuberculosis (TB) continues to be a common disease worldwide. However, the optimal duration of anti-TB medication has not been well established. We therefore compared the efficacy of 6-month and 9-month therapy in the treatment of intestinal TB. Ninety patients definitely diagnosed with intestinal TB were randomized into 6-month (n = 45) or 9-month (n = 45) treatment groups, prospectively. The primary end point was complete response, defined as endoscopic healing of active lesions. Patients were followed up monthly for 3 months after therapy initiation, then every 3 months until the end of therapy, and finally 1 year later. Relapse was assessed 1 year after the end of therapy by patient interview and colonoscopy. Baseline characteristics were similar in the 6-month and 9-month groups. Intention-to-treat analysis revealed no significant differences between the two groups in complete response (6-month group, 93.3%; 9-month group, 91.1%; P = 1.00) or recurrence rate (6-month group, 2.4%; 9-month group, 0.0%; P = 1.00). Median follow-up duration was 39 months in the 6-month group and 32 months in the 9-month group. No surgery was performed on any patient in either group. In conclusion, the 6-month therapy was as effective as 9-month therapy in patients with intestinal TB and may have the additional benefits of reduced treatment cost and increased compliance.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Trial profile.
See this image and copyright information in PMC

References

    1. Akgun, Y. 2005. Intestinal and peritoneal tuberculosis: changing trends over 10 years and a review of 80 patients. Can. J. Surg. 48:131-136. - PMC - PubMed
    1. American Thoracic Society. 1992. Control of tuberculosis in the United States. Am. Rev. Respir. Dis. 146:1623-1633. - PubMed
    1. Bastani, B., M. R. Shariatzadeh, and F. Dehdashti. 1985. Tuberculous peritonitis—report of 30 cases and review of the literature. Q. J. Med. 56:549-557. - PubMed
    1. Blumberg, H. M., W. J. Burman, R. E. Chaisson, C. L. Daley, S. C. Etkind, L. N. Friedman, P. Fujiwara, M. Grzemska, P. C. Hopewell, M. D. Iseman, R. M. Jasmer, V. Koppaka, R. I. Menzies, R. J. O'Brien, R. R. Reves, L. B. Reichman, P. M. Simone, J. R. Starke, A. A. Vernon, et al. 2003. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167:603-662. - PubMed
    1. British Thoracic Association. 1982. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. Am. Rev. Respir. Dis. 126:460-462. - PubMed

Publication types

LinkOut - more resources